XML 26 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 63,047 $ 41,503 $ 63,757
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 211,916 236,966 233,400
Non-cash operating lease costs 10,923 11,141 13,412
Share-based compensation 40,915 31,920 26,601
Provision for credit losses (benefit) on accounts receivable 2,898 2,809 (255)
Deferred income taxes, net (18,822) (30,017) (12,991)
Gain on extinguishment of debt, net 0 0 (11,505)
Loss on sale of businesses 3,780 0 0
Goodwill impairment 85,273 56,850 27,369
Changes in fair value of contingent consideration 0 (200) (2,575)
(Income) loss from equity method investments (11,223) 9,329 7,730
Loss on investments, net 7,654 28,138 53,888
Other 3,601 5,159 3,637
Decrease (increase) in:      
Accounts receivable (153,121) (35,371) 14,948
Prepaid expenses and other current assets (17,153) (8,700) 9,665
Other assets 11,367 (5,574) (16,240)
Increase (decrease) in:      
Accounts payable 171,280 9,419 (20,246)
Deferred revenue 5,043 (6,802) (20,962)
Accrued liabilities and other current liabilities (27,063) (26,608) (33,189)
Net cash provided by operating activities 390,315 319,962 336,444
Cash flows from investing activities:      
Purchases of property and equipment (106,635) (108,729) (106,154)
Acquisition of businesses, net of cash received (217,570) (9,492) (104,094)
Purchases of equity method investment 0 (11,858) 0
Proceeds from sale of equity investments 19,455 3,174 4,527
Investment in available-for-sale securities 0 0 (15,000)
Proceeds from sale of businesses, net of cash divested 7,860 0 0
Other (565) (503) (50)
Net cash used in investing activities (297,455) (127,408) (220,771)
Cash flows from financing activities:      
Payment of debt (134,989) 0 (166,904)
Proceeds from term loan 0 0 112,286
Debt extinguishment costs (277) 0 (756)
Repurchase of common stock (185,181) (108,527) (78,291)
Issuance of common stock under employee stock purchase plan 8,371 8,727 9,431
Proceeds from exercise of stock options 0 0 148
Deferred payments for acquisitions (7,842) (15,241) (16,116)
Other (1,076) 250 (630)
Net cash used in financing activities (320,994) (114,791) (140,832)
Effect of exchange rate changes on cash and cash equivalents (3,598) 7,056 (16,890)
Net change in cash and cash equivalents (231,732) 84,819 (42,049)
Cash and cash equivalents at beginning of year 737,612 652,793 694,842
Cash and cash equivalents at end of year $ 505,880 $ 737,612 $ 652,793